Evidence map›Paper›PMID 36738092›Full record

ArticleEndocrinology, diabetes & metabolism2023

Current patterns of care in low-risk thyroid cancer-A national cross-sectional survey of Australian thyroid clinicians.

Winy Widjaja, Christopher W Rowe, Christopher Oldmeadow, Daron Cope, Elizabeth A Fradgley, Christine Paul, Christine J O'Neill

Open access · goldFull text read
In one paragraph

Article in Endocrinology, diabetes & metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Winy WidjajaSurgical Services, John Hunter Hospital, Newcastle, New South Wales, Australia.ORCID 0000-0003-2251-9332
Christopher W RoweDepartment of Endocrinology, John Hunter Hospital, Newcastle, New South Wales, Australia.
Christopher OldmeadowUniversity of Newcastle, Newcastle, New South Wales, Australia.
Daron CopeSurgical Services, John Hunter Hospital, Newcastle, New South Wales, Australia.
Elizabeth A FradgleyUniversity of Newcastle, Newcastle, New South Wales, Australia.
Christine PaulUniversity of Newcastle, Newcastle, New South Wales, Australia.
Christine J O'NeillSurgical Services, John Hunter Hospital, Newcastle, New South Wales, Australia.ORCID 0000-0002-3122-8660
John Hunter Hospital · AUHunter Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDe-escalated treatment of hemithyroidectomy without radioactive iodine (RAI) is now accepted for patients with low-risk, well-differentiated thyroid cancer (WDTC). The benefit of long-term follow-up care remains controversial. This study aims to describe parameters associated with less than total thyroidectomy, and discharge from specialist follow-up in patients with low-risk WDTC in Australia.

methodsAn online survey was distributed to Australian members of Endocrine Society of Australia, Australian and New Zealand Endocrine Surgeons, and Australian Society of Otolaryngology, Head and Neck Surgery. Clinicians completed a survey of management and follow-up care preferences for four clinical vignettes (all low-risk WDTC).

results119 clinicians (48% endocrinologists, 55% male) answered at least one question. The majority (59%) of respondents recommended less than total thyroidectomy and omission of RAI in patients with WDTC <2 cm. Most (62%) would discharge a patient with micropapillary thyroid cancer within 1 year following total thyroidectomy. In contrast, for WDTC 1-4 cm, >90% of clinicians would continue specialist follow-up for at least 5 years. The majority of clinicians felt that patients experienced disproportionate fear of recurrence and were reassured by follow-up. After multivariable analysis, clinicians who participated in multidisciplinary teams (MDTs) were more likely to choose de-escalated care for both initial treatment (p = .005) and follow-up care (>5 years, p = .05).

conclusionClinician attitudes captured by this survey reflect recent changes in guidelines towards hemithyroidectomy for low-risk WDTC, particularly amongst MDT attendees. There is a need to further examine the impact of de-escalated care on fear of recurrence and quality of life in thyroid cancer survivors.

Indexed as

Thyroid NeoplasmsAustraliaCross-Sectional StudiesFemaleHumansIodine RadioisotopesMaleQuality of LifeIodine Radioisotopescancer survivorshipfear of cancer recurrencehealth-related quality of lifemulti-disciplinary teamthyroid cancerthyroidectomy

Identifiers

PMID36738092
PMCPMC10000626
OpenAlexW4319216059

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read163
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.